Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer

被引:0
作者
Alice Mogenet
Pascal Finetti
Emilie Denicolai
Laurent Greillier
Pascaline Boudou-Rouquette
François Goldwasser
Gwenael Lumet
Michele Ceccarelli
Daniel Birnbaum
Davide Bedognetti
Emilie Mamessier
Fabrice Barlesi
François Bertucci
Pascale Tomasini
机构
[1] Aix Marseille Univ,Multidisciplinary Oncology and Therapeutic Innovations Department
[2] APHM,Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR1068, CNRS UMR725, Laboratoire d’Oncologie Prédictive
[3] INSERM,Department of Medical Oncology, Cochin Hospital, AP
[4] CNRS,HP, Paris
[5] CRCM,Sylvester Comprehensive Cancer Center, Department of Public Health Sciences
[6] Hôpital Nord,Division of Translational Medicine, Research Branch
[7] Aix Marseille Univ,Department of Internal Medicine and Medical Specialties
[8] France–University of Paris Descartes,Department of Medical Oncology, Institut Paoli
[9] ARIANE,Calmettes
[10] CARPEM,undefined
[11] University of Miami Miller School of Medicine,undefined
[12] Sidra Medicine,undefined
[13] University of Genoa,undefined
[14] Paris-Saclay University and Medical Oncology,undefined
[15] Gustave Roussy,undefined
[16] Aix Marseille Univ,undefined
来源
Journal of Translational Medicine | / 21卷
关键词
Lung cancer; ICR signature; Immune therapy; Biomarkers; Immune checkpoints inhibitors; Transcriptomics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 322 条
  • [31] Cooper W(2020)Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response J Immunother Cancer 77 3540-61
  • [32] Dacic S(2017)Immune-related gene expression profiling after PD-1 blockade in non-small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma Cancer Res 27 202-396
  • [33] Hirsch FR(2021)Genome and transcriptome biomarkers of response to immune checkpoint inhibitors in advanced solid tumors Clin Cancer Res 511 543-2116
  • [34] Jain D(2014)Comprehensive molecular profiling of lung adenocarcinoma Nature 489 519-408
  • [35] Aguiar PN(2012)Comprehensive genomic characterization of squamous cell lung cancers Nature 16 4864-391
  • [36] De Mello RA(2010)Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types Clin Cancer Res 39 782-530
  • [37] Hall P(2013)Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer Immunity 107 6994-237
  • [38] Tadokoro H(2010)A pathway-based classification of human breast cancer Proc Natl Acad Sci USA 160 48-641
  • [39] de Lima Lopes G(2015)Molecular and genetic properties of tumors associated with local immune cytolytic activity Cell 8 e000974-1286
  • [40] Kerr KM(2020)Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma J Immunother Cancer 30 385-13781